Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters

Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer

(2010) Jung Hyun Kwon et al.   BMC CANCER

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma

(2010) Higinia R. Cárdenes et al.   Clinical & Translational Oncology

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic Complication

(2010) Seok Hyun Son et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation-Associated Liver Injury

(2010) Charlie C. Pan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Extrapolation of Normal Tissue Complication Probability for Different Fractionations in Liver Irradiation

(2009) An Tai et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

(2009) Mark T. Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

(2009) Kyle E. Rusthoven et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

(2008) Regina V. Tse et al.   JOURNAL OF CLINICAL ONCOLOGY